Tag: Covid-19
-
Infographic – U.S. Public Split on Contact Tracing
While majorities of Americans say they’re willing to take part in contact tracing activities during the Covid-19 pandemic, large parts of the public are still reluctant.
-
Trial Shows Covid-19 Vaccine Safety, Immune Response
First results from an early-stage clinical trial show an RNA-based vaccine to prevent Covid-19 infections is safe and produces a complex immune response.
-
Inhaled Dry-Powder Covid-19 Antibodies in the Works
Two biotechnology companies are developing synthetic antibodies to treat Covid-19 infections formulated as an inhaled dry powder rather than an infusion.
-
Wearable Data Help Detect Covid-19 Cases
Data from smart watches and fitness trackers, when combined with symptom reports, can show that the wearers likely have Covid-19 infections.
-
Covid-19 Drug Biotech Raises $300M in IPO
A company developing a treatment for Covid-19 infections taken as a tablet instead of infusion issued its initial public offering, or IPO, for common stock.
-
FDA to Use Lung Chip Model for Covid-19 Testing
The Food and Drug Administration plans to use organ-on-chip models to test mechanisms for preventing Covid-19 infections, and other processes.
-
Covid-19 Antibodies Cut Viral Load, Medical Visits
Interim results from a clinical trial show a synthetic antibody drug reduces viral burden and medical visits among non-hospitalized Covid-19 patients.
-
200M Covid-19 Vaccine Doses Donated to Int’l Effort
Sanofi and GlaxoSmithKline are offering 200 million doses of their Covid-19 vaccine for a project devoted to making vaccines equitably available worldwide.
-
Novartis Gains Synthetic Protein Therapies for Covid-19
Global drug maker Novartis is gaining access to two Covid-19 therapy candidates made from a library of synthetic protein components.
-
Lilly, NIH Halt Covid-19 Antibody Therapy Trial
Drug maker Eli Lilly and National Institutes of Health are stopping a clinical trial testing a synthetic antibody to treat hospitalized Covid-19 patients.